DexCom, Inc. Stock News

DXCM Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

DexCom stock has fallen 41% this year, but investor sentiment for the maker of glucose monitoring devices could be changing.

SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”), have until October 21, 2024 to seek appointment as lead plaintiff of the DexCom class action lawsuit. Captioned Alonzo v. DexCom, Inc., No. ...

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #DXCM--Robbins LLP is Investigating Allegations that DexCom Inc. (DXCM) Misled Investors Regarding its Business Prospects.

SAN FRANCISCO, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

RADNOR, Pa, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between Janu...

DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage.

NEW YORK , Aug. 30, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Class Period"). A class action has already been filed.